GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (FRA:0RY) » Definitions » Short-Term Capital Lease Obligation

Rhythm Biosciences (FRA:0RY) Short-Term Capital Lease Obligation : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Rhythm Biosciences Short-Term Capital Lease Obligation?

Rhythm Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.00 Mil.

Rhythm Biosciences's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.05 Mil) but then declined from Jun. 2023 (€0.05 Mil) to Dec. 2023 (€0.00 Mil).

Rhythm Biosciences's annual Short-Term Capital Lease Obligation increased from Jun. 2021 (€0.00 Mil) to Jun. 2022 (€0.06 Mil) but then declined from Jun. 2022 (€0.06 Mil) to Jun. 2023 (€0.05 Mil).

Rhythm Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Rhythm Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Short-Term Capital Lease Obligation Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial - 0.03 - 0.06 0.05

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.06 - 0.05 -

Rhythm Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Rhythm Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (FRA:0RY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (FRA:0RY) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
ASX:LDX ASX:CTE ASX:IIQ ASX:BDX ASX:GTG ASX:IBX ASX:GSS ASX:MAP TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
RHY:Australia
Address
30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Website
https://www.rhythmbio.com
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (FRA:0RY) Headlines

No Headlines